Inventor · disambiguated record
Mathieu Rafaël Pizzonero
Also filed as: PIZZONERO MATHIEU RAFAËL
9 granted patents·3 pending applications·6 citations·filing 2012–2021
81Inventor score
Files withABBVIE OVERSEAS SARL6ABBVIE SARL3ABBVIE S À R L1GALAPAGOS NV1SANIÈRE LAURENT RAYMOND MAURICE1
Top patents by PatentIndex Score
12 records- 0182US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 0279US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 0373US9796711B2Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of useABBVIE S ÀR L·Filed 2016·Granted Oct 24, 2017·2 cites·42 claims
- 0472US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 0571US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 0671US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 0771US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 0869US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 0961US8759334B2Compounds useful for the treatment of metabolic and inflammatory diseasesSANIÈRE LAURENT RAYMOND MAURICE·Filed 2012·Granted Jun 24, 2014·2 cites·17 claims
- 1055US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 1148US2014371198A1Novel compounds useful for the treatment of metabolic and inflammatory diseasesGALAPAGOS NV·Filed 2014·Application pending·0 cites
- 1235US10130622B2Compounds for treatment of cystic fibrosisABBVIE SARL·Filed 2016·Granted Nov 20, 2018·0 cites·33 claims
Join the waitlist — get patent alerts
Get an alert when Mathieu Rafaël Pizzonero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →